PATENT CLAIM ANALYSIS

Application Number: 15745441
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "026000"]

Abstract:
Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.

Claim (Index 22):
A method of reducing intraocular pressure (IOP) in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of  claim 1 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14913366', '15276479', '15326262', '13697302', '10911300']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.73551338254362
- 35 USC 102 Novelty (BERT): 0.5200955829083964
- Combined Prediction Score: 0.7139716025800976
- Mean Citation Score: 217.841656
- Max Citation Score: 302.30185
- Similarity Product: 193.72578235020936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test